Suivre
Parvathy Venugopal
Parvathy Venugopal
Centre for Cancer Biology
Adresse e-mail validée de sa.gov.au
Titre
Citée par
Citée par
Année
Increased proliferation and analysis of differential gene expression in human Wharton's jelly-derived mesenchymal stromal cells under hypoxia
U Nekanti, S Dastidar, P Venugopal, S Totey, M Ta
International journal of biological sciences 6 (5), 499, 2010
2282010
Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications
U Nekanti, L Mohanty, P Venugopal, S Balasubramanian, S Totey, M Ta
Stem cell research 5 (3), 244-254, 2010
1672010
Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton’s jelly derived mesenchymal stem cells? A comparative study
P Swamynathan, P Venugopal, S Kannan, C Thej, U Kolkundar, ...
Stem cell research & therapy 5 (4), 1, 2014
1292014
Higher propensity of Wharton's jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow
S Balasubramanian, C Thej, P Venugopal, N Priya, Z Zakaria, ...
Cell biology international 37 (5), 507-515, 2013
802013
Isolation, characterization, and gene expression analysis of Wharton’s jelly-derived mesenchymal stem cells under xeno-free culture conditions
P Venugopal, S Balasubramanian, AS Majumdar, M Ta
Stem cells cloning 4 (1), 39-50, 2011
652011
Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells
S Balasubramanian, P Venugopal, S Sundarraj, Z Zakaria, AS Majumdar, ...
Cytotherapy 14 (1), 26-33, 2012
642012
Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes.
CE Chong, P Venugopal, PH Stokes, YK Lee, PJ Brautigan, DTO Yeung, ...
Leukemia, 2017
562017
Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy
CN Hahn, P Venugopal, HS Scott, DK Hiwase
Immunological reviews 263 (1), 257-278, 2015
552015
Revealing Missing Human Protein Isoforms Based on Ab Initio Prediction, RNA-seq and Proteomics
Z Hu, HS Scott, G Qin, G Zheng, X Chu, L Xie, DL Adelson, BE Oftedal, ...
Scientific reports 5, 2015
522015
Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan anemia patient
P Venugopal, S Moore, DM Lawrence, AJ George, RD Hannan, SCE Bray, ...
haematologica, haematol. 2017.166678, 2017
302017
Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia.
CN Hahn, PJ Brautigan, CE Chong, A Janssan, P Venugopal, Y Lee, ...
Leukemia 29 (8), 1795, 2015
162015
Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss
P Venugopal, L Gagliardi, C Forsyth, J Feng, K Phillips, M Babic, ...
BMC Medical Genetics 21 (1), 1-5, 2020
32020
Clinical implications of transient myeloproliferative disorder in a neonate without Down syndrome features
V Carruthers, M Nicola, P Venugopal, CN Hahn, HS Scott, T Revesz
Journal of paediatrics and child health 53 (10), 1018-1020, 2017
32017
An Integrative Genomic Approach to Examine Mutations and Biological Pathways Associated with Hematological Malignancy Development in DDX41 Mutated Families
P Venugopal, JJC Cheah, L Eshraghi, NH Shahrin, C Homan, J Feng, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
22019
Australian Familial Haematological Cancer Study-Findings from 15 Years of Aggregated Clinical, Genomic and Transcriptomic Data
CN Hahn, M Babic, PJ Brautigan, P Venugopal, K Phillips, J Dobbins, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
22019
Familial Clustering of Hematological Malignancies: Harbingers of Wider Germline Cancer Susceptibility
AL Brown, M Babic, A Schreiber, J Feng, J Dobbins, P Arts, P Wang, ...
Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019
12019
IMPLICATIONS OF REVERTANT SOMATIC MOSAICISM IN BONE MARROW FAILURE SYNDROMES
P Venugopal, M Babic, C Barnett, S Bray, A Brown, J Cheah, R D'Andrea, ...
Experimental Hematology 76, S90, 2019
12019
Identification and characterisation of genetic lesions that predispose to and gene expression patterns that contribute to Myeloid malignancies
P Venugopal
2016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–18